Showing 759 news articles about Hepatitis C treatment

Filters Content type: Editors' picks Topic: Hepatitis C treatment

Direct-acting antiviral medicines interfere with different steps of the hepatitis C lifecycle. A combination of drugs may be co-formulated into a single pill. Modern treatment typically lasts for two or three months, usually does not cause side-effects and cures more than 95% of treated people.

Hepatitis C treatment

Australia: People Who Use Drugs Welcome Decision to ‘Seize the Day’ on New Hepatitis C Treatments

Editor's pick
Australian Injecting & Illicit Drug Users League
21 December 2015
Hepatitis C treatment

Concern over hepatitis C drug costs only the beginning, health officials say

Editor's pick
The News Tribune
21 December 2015
Hepatitis C treatment

Hopes Hepatitis C could be wiped out in Australia as the Federal Government pledges $1b to subsidise 'breakthrough' cures

Editor's pick
9news.com.au
21 December 2015
Hepatitis C treatment

Study Probes Value of Hepatitis C Treatment at All Stages of Liver Fibrosis

Editor's pick
MD Magazine
10 December 2015
Hepatitis C treatment

European Physicians Report Strong but Variable Uptake of All-Oral Interferon-Free Hepatitis C Virus Regimens Across EU5 Countries

Editor's pick
Decision Resources press release
9 December 2015
Pharmaceutical industry

A New Look Behind the Pricing of a $1,000 Pill

Editor's pick
Open Society Foundations
8 December 2015
Finance & funding

The Impact Of New Hepatitis C Drugs On National Health Spending

Editor's pick
Health Affairs (blog)
8 December 2015
Pharmaceutical industry

Gilead Used `Revenue-Driven Pricing' on Hep C Drug, Senators Say

Editor's pick
Bloomberg
1 December 2015
Access to healthcare

Real life Dallas Buyers Club operation helps hepatitis C patients with free drugs

Editor's pick
Sydney Morning Herald
1 December 2015
Hepatitis C treatment

South Africa’s ‘other’ virus

Editor's pick
Health-e
1 December 2015
Hepatitis C treatment

Morocco without hepatitis C in 2020

Editor's pick
Morocco World News
27 November 2015
Hepatitis C treatment

UK: Hep C patients to get NHS access to three new therapies

Editor's pick
Pharma Times
27 November 2015
Hepatitis C treatment

Pricey HCV Drugs Worth the Cost

Editor's pick
MedPage Today
27 November 2015
Hepatitis C treatment

The Medicines Patent Pool Signs Licence with Bristol-Myers Squibb to Increase Access to Hepatitis C Medicine Daclatasvir

Editor's pick
Medicines Patent Pool
23 November 2015
Finance & funding

Why We Should Be Willing to Pay for Hepatitis C Treatment

Editor's pick
Huffington Post
23 November 2015
Hepatitis C treatment

Leading liver doctors: Hepatitis C patients must be treated

Editor's pick
American Association for the Study of Liver Diseases press release
17 November 2015
Hepatitis C treatment

Pricing Pressures: How the Business of Medicine Affects the Price of Therapy

Editor's pick
Healio HCV Next
16 November 2015
Hepatitis C treatment

Medicare will spend $9 billion on Hepatitis-C drugs this year

Editor's pick
PBS NewsHour
16 November 2015
Hepatitis C treatment

U.S. FDA approves new indications for Harvoni®, Gilead’s once-daily single tablet regimen for chronic hepatitis C

Editor's pick
Gilled press release
13 November 2015
Access to healthcare

The Medicines Patent Pool Expands Mandate to Hepatitis C and Tuberculosis Treatment

Editor's pick
Medicines Patent Pool
9 November 2015
Hepatitis C treatment

New hepatitis C drug can slow heart rate

Editor's pick
Health24
9 November 2015
Hepatitis C treatment

The Dark Side of Letting Insurance Payers Dictate Hepatitis C Treatment

Editor's pick
Huffington Post
2 November 2015
Hepatitis C treatment

Hepatitis C: behind new wonder drugs lies a terrible dilemma

Editor's pick
The Conversaion
29 October 2015
Hepatitis C treatment

Report: Hepatitis C in Eastern Europe and Central Asia: Civil society response to the epidemic

Editor's pick
International HIV/AIDS Alliance Ukraine
29 October 2015